Table 4.
Results of IgG anti-spike-protein antibodies test and laboratory tests after vaccination with BBIBP-CorV or ChAdOx1 vaccines.
| Question | BBIBP-CorV | ChAdOx1 | |
|---|---|---|---|
| 1—Have you had corona infection before? | |||
| Yes | 23% | ||
| No | 77% | ||
| 2—Results of anti-spike-protein antibodies test(IgG) | 100% | ||
| Positive (more than 1) | 100% | ||
| Negative (less than 1) | 0% | ||
| 3—Average of positive results of quantitative anti-spike-protein antibodies test (IgG) for the cases with a previous coronavirus infection during the four months before vaccination (after three weeks of second dose) | More than 250 AU/mL | ||
| 4—Average of positive results of quantitative anti-spike- protein antibodies test (IgG) for the cases without previous coronavirus infection before vaccination (after three weeks of second dose) | 40 AU/mL | 220 AU/mL | |
| 5—Average of positive results of quantitative anti-spike-protein antibodies test (IgG) for the cases without previous coronavirus infection before vaccination (after three weeks of first dose) | 0 | 24 AU/mL | |
| 6—Average of positive results of quantitative anti-spike-protein antibodies test (IgG) for the cases without previous coronavirus infection before vaccination (after three days of first dose) | 0 | 0 | |
| 7—Gender | |||
| Positive results of quantitative IgG anti-spike-protein antibodies test after second-dose vaccination | |||
| Male | 54% | 19% | |
| Female | 46% | 81% | |
| Negative results of quantitative IgG anti-spike-protein antibodies test after second-dose vaccination | |||
| Male | 26% | 0 | |
| Female | 74% | 0 | |
| Average of positive results of quantitative IgG anti-spike-protein antibodies test after second-dose vaccination. | |||
| Male | 82 AU/mL | 230 AU/mL | |
| Female | 48 AU/mL | 240 AU/mL | |
| 8—Age in years | |||
| Positive results of quantitative IgG anti-spike-protein antibodies test after second-dose vaccination | |||
| From 18 to 40 years | 74% | 51% | |
| From 41 to 60 years | 20% | 32% | |
| More than 60 years | 6% | 12% | |
| Negative results of quantitative IgG anti-spike-protein antibodies test after second-dose vaccination | |||
| From 18 to 40 years | 44% | 0 | |
| From 41 to 60 years | 34% | 0 | |
| More than 60 years | 22% | 0 | |
| Average of positive results of quantitative IgG anti-spike-protein antibodies test after second-dose vaccination | |||
| From 18 to 40 years | 72 AU/mL | 250 AU/mL | |
| From 41 to 60 years | 56 AU/mL | 234 AU/mL | |
| More than 60 years | 29 AU/mL | 211AU/mL | |
| 9—Average of laboratory factors for the positive IgG anti-spike-protein antibodies cases | |||
| Hemoglobin | 12.6 | 12.5 | |
| Platelets | 263 | 241.8 | |
| Leucocytes | 7.9 | 6.7 | |
| Neutrophils | 53% | 59.6% | |
| Lymphocytes | 42% | 32.4% | |
| Erythrocyte sedimentation rate (ESR) | 21 | 23 | |
| Aspartate aminotransferase (SGOT) | 20 | 18.8 | |
| Alanine aminotransferase (SGPT) | 20.5 | 18.9 | |